NCT03736486

Brief Summary

The Mil Familias Program is a 10-year initiative to reduce the burden of cardio-metabolic disease among Latino families in the Central Coast of California. The Mil Familias Program involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, measuring the 5 determinants of human health: genetics, biology, behavior, psychology and environment, training Latino community health workers ("Especialistas") , creating a Living Information (bio)Bank and planning culturally-relevant interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 9, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

January 9, 2019

Status Verified

January 1, 2019

Enrollment Period

1.4 years

First QC Date

October 30, 2018

Last Update Submit

January 8, 2019

Conditions

Keywords

Type 2 diabetesCardio-metabolic diseaseLatinoHispanicEspecialista

Outcome Measures

Primary Outcomes (1)

  • Success (evaluated by Yes/No format) recruiting and establishing a pilot cohort of 100 Latino adults with Type 2 Diabetes and creating data collection methods to describe genetics, biology, behavior, psychology, & environment in Type 2 Diabetes

    Mil Familias Program Pilot will measure genetic influences by a family medical history \& biobank blood samples. Biologic influences will include laboratory blood draw, physical exam with vital signs \& waist circumference measurement, and complete medical \& medication history with female menopause, pregnancy, \& gestational diabetes status. Behavior influences will include sleep, stress, drug abuse, and diabetes self-assessment management questionnaires. Wearable devices will measure physical activity. Psychological influences will include Patient Health Questionnaire-9, Brief Perceived Ethnic Discrimination Questionnaire Community Version, and Short Form Health Survey. Social/environmental influences will include socio-demographics, Brief Acculturation Scale for Hispanics, personal opinions about type 2 diabetes, and questionnaires \[Short Assessment of Health Literacy, Trust in Physician, Health Leads Screening Toolkit, and U.S. Household Food Security Survey\].

    1 year

Secondary Outcomes (22)

  • Socio-demographics measured by questionnaire - including age, gender, race/ethnicity, contact information, number in household, income, education, marital status, occupation, insurance status, immigration status, alcohol & tobacco use, and birth place

    Beginning of study - Baseline visit 1

  • Self-assessment of diabetes management measured by the American Diabetes Association questionnaire, Participant Self-Assessment of Diabetes Management

    Beginning of study - Baseline visit 1

  • Food security assessed by U.S. Household Food Security Survey Module: Six-item short form

    Beginning of study - Baseline visit 1

  • Social needs screening assessed by the Health Leads Screening Toolkit

    Beginning of study - Baseline visit 1

  • Number of visits to a healthcare provider in the last year and difficulty in traveling to a healthcare provider measured by electronic medical record and interview

    Beginning of study - Baseline visit 1

  • +17 more secondary outcomes

Other Outcomes (2)

  • Engagement of a local consortium of partners to implement participant recruitment; data collection, storage, and analysis; healthcare access; and/or intervention measured by the number of major operational partnerships with formal agreements

    1 year

  • Success measured by the number of health care workers trained, upskilled, and employed to be community health care workers (Especialistas) and the number of participant encounters with a trained health care worker

    1 year

Study Arms (1)

Type 2 Diabetes

Male and female adults of Hispanic and/or Latino heritage with an established diagnosis of Type 2 diabetes.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 125 individuals may be screened and enrolled with the prediction of 20% screen-fail or dropout and 100 people completing SB1K Phase I.

You may qualify if:

  • Males or females ≥ 18 years of age at Visit 1 (screening and enrollment).
  • Self-reported Hispanic and/or Latino heritage.
  • Currently residing in Santa Barbara County, California.
  • Established diagnosis of Type 2 diabetes for at least one year prior to enrollment date.
  • Signed and dated written informed consent by the date of Visit 1.
  • Based on the research staff's judgment, subject must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.

You may not qualify if:

  • Diagnosed severe cardiovascular disease, within the 6 months prior to enrollment Visit 1, defined as: previous stroke; decompensated heart failure New York Heart Association class III or IV; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty.
  • Life expectancy \< 2 years.
  • Any active clinically significant disease or disorder, which in the investigator's opinion could interfere with the participation of the trial.
  • Mental incapacity, psychiatric disorder, unwillingness or language barriers precluding comprehension of study activities and informed consent.
  • Participation in other trials involving medication or device within 1 month prior to Visit 1.
  • Known or suspected abuse of alcohol, narcotics, or illicit drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sansum Diabetes Research Institute

Santa Barbara, California, 93105, United States

Location

Related Publications (2)

  • Glantz NM, Morales JM, Bevier WC, Larez A, Hoppe CB, Duncan I, Mackenzie A, Kerr D. Insurance Status and Biological and Psychosocial Determinants of Cardiometabolic Risk Among Mexican-Origin U.S. Hispanic/Latino Adults with Type 2 Diabetes. Health Equity. 2020 May 4;4(1):142-149. doi: 10.1089/heq.2019.0119. eCollection 2020.

  • Bevier W, Glantz N, Hoppe C, Morales Glass J, Larez A, Chen K, Kerr D. Self-reported and objectively measured physical activity levels among Hispanic/Latino adults with type 2 diabetes. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000893. doi: 10.1136/bmjdrc-2019-000893.

Biospecimen

Retention: SAMPLES WITH DNA

Serum, Plasma, Buffy coat (white cells)

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • David Kerr, M.D.

    Sansum Diabetes Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 9, 2018

Study Start

August 24, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

January 9, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will share

All individual participant data (IPD) that underlie results in publications.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will be made available after the primary publication of each analysis.
Access Criteria
Data Sharing Agreements will be formulated by a committee of study investigators and community and industry partners.
More information

Locations